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Trypanosoma cruzi antioxidant enzymes are among the factors that guarantee parasite survival and main-
tain infection, enabling T. cruzi to cope with oxidative stress. Herein, the expression of cytosolic (TcCPx)
and mitochondrial (TcMPx) tryparedoxin peroxidases was evaluated in tissue culture-derived trypom-
astigotes upon incubation with different concentrations of H2O2. TcCPx expression slightly increased
(5.4%) in cells submitted to 10 lM H2O2 treatment when compared to the control, but decreased when
higher H2O2 concentrations (20–50 lM) were employed. Under these conditions, TcMPx expression
increased (53%) with 10 lM-treatment compared to the control, followed by a reduction that reached
46% of the control when using the highest concentration tested. Interestingly, in the supernatant of the
incubations, TcCPx, but not TcMPx, was detected, and its levels increased concomitantly with its
decreased expression in the intracellular compartment. Our data show that peroxiredoxins in the tissue
culture-derived trypomastigote can be modulated under oxidative stress and are present in higher
amounts when compared to the epimastigote stage of T. cruzi. Additionally, due to the different expres-
sion patterns observed upon H2O2-treatment, each peroxiredoxin may play a distinct role in protecting
the parasite under oxidative stress conditions.
 2012 Elsevier Inc. Open access under the Elsevier OA license.redo Peloso, Universidade Estadual de Campinas, Instituto de Biologia, Departamento de Bioquímica, Caixa Postal: 6109,
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American trypanosomiasis is a potentially life-threatening par-
asitic disease caused by Trypanosoma cruzi. There are 10 million
people infected worldwide, mostly in Latin America, and approxi-
mately 25 million people are at risk of contracting the disease
(World Health Organization, 2010). It was estimated that in
2008, more than 10,000 people died from this parasitic infection
(World Health Organization, 2010). Currently, no vaccine has been
developed against T. cruzi (Dumonteil, 2009), and the drugs cur-
rently used, benznidazole or nifurtimox, not only have a limited
efﬁcacy but also have several side effects (Wilkinson et al., 2008).
Therefore, the search for new targets for chemotherapy is a major
challenge. Among the targets, the parasite antioxidant system has
attracted attention due to its uniqueness in the trypanosomatids.
T. cruzi’s life cycle includes invertebrate and vertebrate hosts
and three well-deﬁned forms: the epimastigote (insect vector),
the trypomastigote (the bloodstream and metacyclic forms, in ver-
tebrate and invertebrate hosts, respectively) and the amastigote
(the intracellular form in vertebrate hosts) (Murray, 2006). During
its life cycle, the parasite goes through a series of morphological
and biochemical modiﬁcations, providing each stage with the
capacity to survive in a new environment (Díaz et al., 2011). In
the vertebrate host, T. cruzi has to deal with high levels of reactive
oxygen (ROS) and nitrogen (RNS) species, especially H2O2 and per-
oxynitrite (ONOO), which are produced by macrophages (Kiers-
zenbaum et al., 1974). It is now clear that the capacity of T. cruzi
to evade the host’s oxidative response directly correlates with its
infectivity (Piacenza et al., 2009a).
T. cruzi’s antioxidant defenses consist of a series of pathways
centered in the trypanothione (T(SH)2, (N1,N8-bisglutathionylspe-
rmidine)), a low molecular mass dithiol unique to the trypanoso-
matids (Flohe et al., 1999). T(SH)2 is synthesized by
trypanothione synthetase (TS), an enzyme also absent in the verte-
brate host, and is maintained in its reduced form by a NADPH-
dependent ﬂavoenzyme, trypanothione reductase (TR). T(SH)2
transfers the reducing equivalents to tryparedoxin, an intermedi-
ate electron donor that ﬁnally transfers the reducing equivalents
to peroxidases, which in turn reduce hydroperoxides (Irigoín
et al., 2008; Krauth-Siegel and Comini, 2008; Wilkinson and Kelly,
2003). Five distinct peroxidases have been identifed in T. cruzi, each
differing in their substrate speciﬁcity and intracellular location
(Wilkinson and Kelly, 2003). Tryparedoxin peroxidases are located
in the cytosol (TcCPx, Genbank accession number: AJ012101) and
in the mitochondrion (TcMPx, Genbank accession number:
AJ006226) with low similarity (57%) between the two (Wilkinson
et al., 2000) and detoxify H2O2, small chain organic hydroperoxides
(Wilkinson et al., 2000) and peroxynitrite (Piacenza et al., 2008;
Pineyro et al., 2011). The TcMPx is located around the kinetoplast,
suggesting its possible role in protecting mitochondrial DNA
against peroxide-mediated damage (Wilkinson et al., 2000). Ascor-
bate peroxidase (APx) also detoxiﬁes H2O2 and is located in the
endoplasmic reticulum (Wilkinson et al., 2002a). Glutathione per-
oxidase-I (cytosol and glycosome) and -II (endoplasmic reticulum)
confer resistance against phospholipids and fatty acids hydroper-
oxides (Wilkinson et al., 2002a, 2002b).
Previous data have shown the importance of peroxiredoxins as
key enzymes for T. cruzi. Parasites overexpressing TcCPx or TcMPx
were able to infect and multiplicate more efﬁciently in infectivity
experiments (Piacenza et al., 2009a; Piacenza et al., 2008; Piñeyro
et al., 2008). Overexpression of TcCPx or TcMPx has been shown to
confer a high level of protection for T. cruzi epimastigotes against a
broad range of peroxynitrite concentrations (0–200 lM and
0–400 lM for TcMPx or TcCPx overexpressing cells, respectively)(Piacenza et al., 2008). Additionally, signiﬁcant differences related
to the levels of H2O2 released by the mitochondrial respiratory
chain (MRC) in T. cruzi epimastigotes overexpressing these perox-
iredoxins were only observed when the MRC was inhibited by anti-
mycin A or thenoyltriﬂuoracetone (Peloso et al., 2011).
Interestingly, in T. cruzi, the levels of these peroxiredoxins and TS
are increased in metacyclogenesis but not TR or APx, and this in-
crease is more pronounced in the more virulent strains (Piacenza
et al., 2009b). In T. cruzi epimatigotes, TcCPx or TcMPx overexpres-
sion has been shown to confer a higher resistance to H2O2 (Peloso
et al., 2011). Interestingly, in Leishmania infantum, overexpression
of these peroxiredoxins leads to variable resistance to oxidative
stress, where parasites overexpressing the cytosolic peroxidase
were more resistant to H2O2-treatment, while parasites that
overexpressed the mitochondrial homolog were more resistant to
t-butyl hydroperoxide (Castro et al., 2002).
Most of the protein expression studies in T. cruzi have been per-
formed in epimastigotes or metacyclic trypomastigotes. However,
our particular interest in understanding the re-infection of the ver-
tebrates by T. cruzi released by infected cells, associated with the
facility in obtaining pure tissue - cultured derived trypomastigotes
led us to choose this form. Taking this into account and the rele-
vance of these enzymes for T. cruzi, in this study, we evaluated
TcCPx and TcMPx expression in tissue culture-derived trypom-
astigotes in the presence or absence of H2O2-treatment. To our
knowledge, this is the ﬁrst report in T. cruzi that shows the release
of TcCPx, but not TcMPx, into the incubation medium and the mod-
ulation of these peroxidases under oxidative stress conditions in
tissue culture-derived trypomastigotes.2. Material and methods
2.1. Cell culture
2.1.1 Epimastigotes (Y strain) were grown at 28 C in LIT med-
ium containing 20 mg/L hemin and 10% fetal calf serum as de-
scribed previously (Castellani et al., 1967). During the early
stationary phase, the cells were harvested by centrifugation
(2500 rpm, 5 min at 4 C) and washed in phosphate-buffered saline
(PBS, pH 7.3) and the number of cells determined in a Neubauer
chamber.
2.1.2 Trypomastigotes (Y strain) were maintained in culture by
infection of LLC-MK2 cells in culture medium DMEM with 2% fetal
calf serum. After 5 days of infection, the parasites released into the
extracellular medium were centrifuged (5000 rpm for 10 min) and
the number of cells was determined in a Neubauer chamber.2.2. Preparation of protein extracts
T. cruzi epimastigotes (5.2  106 cells/mL) were incubated in
DMEM without H2O2 at 28 C for 2 h, and the trypomastigotes
(5  107 cells/mL) were incubated in DMEM in the presence of
0–50 lM H2O2 at 37 C for 2 h. The cells and the supernatant
(H2O2-incubated medium) were separated by centrifugation, as de-
scribed above. Afterwards, the cells were washed three times in
PBS in the presence of phosphatase and protease inhibitors
(5 mM NaF, 2 mM Na3VO4, 50 lM sodium b-glycerophosphate,
1 mM PMSF and Protease Inhibitor Cocktail (SIGMA–ALDRICH)). Fi-
nally, the pellet was ressuspended in 500 lL of loading buffer
(50 mM Tris–HCl pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glyc-
erol and 0.7 M b-mercaptoethanol).
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The supernatant from the incubation of trypomastigotes with or
without H2O2 was ﬁltered (pore 0.22 lM) and lyophilized. Then,
50 mg of the resulting powder was ressuspended in 150 lL of
PBS, and 10 lL of loading buffer was added to 30 lL of this
solution.2.4. Western blotting
The recombinant proteins TcCPx and TcMPx were obtained as
hexahistidine-tag proteins cloned in the pQE30 vector (Qiagen)
and were expressed in the M15 Escherichia coli strain and puriﬁed
in a Ni2+-NTA resin column. Polyclonal antibodies a-TcCPx and
a-TcMPx were obtained as described (Piñeyro et al., 2008).
Proteins from the cell extracts (equivalent to 2  107 cells) and
the H2O2-incubation medium (30 lL of the reconstituted lyophi-
lized supernatant) were separated by 10% SDS–PAGE and electro-
blotted onto a nitrocellulose membrane using the XCell™ II mini
cell system (Novex™). Membranes were blocked by incubation
with 5% instant, non-fat, dried milk in PBST (PBS/0.05% Tween
20) for 1 h at 4 C, washed in PBST for 30 min and incubated in
the presence of polyclonal antibodies against T. cruzi TcMPx
(1:2500) or TcCPx (1:5000) for 1 h or 24 h at 4 C in the case of
the supernatant proteins. After three 15 min washes with PBST,
the membranes were incubated with HRP-linked anti-rabbit IgG
(Cell Signaling Technology, 1:6000 dilution) for 1 h at room
temperature and washed three times with PBS (Nogueira et al.,
2006; Peloso et al., 2011). The proteins were revealed using the
Super Signal Detection Kit (Pierce). Data were analyzed by the
Scion Imaging Program and normalized by the loading control
(a-TcGAPDH), except for the supernatant proteins that were
stained by Coomassie Blue.2.5. Morphological analysis of tissue-culture derived trypomastigotes
treated with H2O2
Tripomastigotes (5  107 cells/mL) were incubated in DMEM in
the presence of 0–50 lMH2O2 at 37 C for 2 h. After this period the
cells were washed in PBS, ﬁxed in 4% paraformaldehyde and ana-
lyzed in a Zeiss LSM 780-NLO reverse confocal on an Axio Observer
Z.1microscope (Carl Zeiss AG, Germany).2.6. Statistical analysis
Data represent the average ± standard deviation of at least two
independent experiments performed in duplicate. Comparisons
were determined using the Student’s t-test with Origin 6.0 soft-
ware (Student’s t-test), and p < 0.05 was considered to be statisti-
cally signiﬁcant.3. Results
During T. cruzi’s life cycle, the enzyme proﬁle varies among the
different forms to allow the parasite to survive in an environment
with different challenges (Díaz et al., 2011). TcCPx and TcMPx are
upregulated during metacyclogenesis, allowing the parasite to deal
with the oxidative stress generated by macrophages (Piacenza
et al., 2009b). The cells that are able to survive this oxidative chal-
lenge can subsequently escape from the vacuole and establish the
infection. Most of the H2O2-challenge studies and subsequent eval-
uation of tryparedoxin peroxidases expression were investigated in
epimastigotes and in the metacyclic trypomastigotes, but no data
was obtained for trypomastigote, the mammalian infective stage.Herein, the level of these enzymes due to H2O2-challenge in tissue
culture-derived trypomastigotes was determinated.
The sensibility of trypomastigotes to H2O2 in comparison to
epimastigotes was ﬁrst veriﬁed by incubation of the parasites with
different concentrations of H2O2 (0–200 lM) for 2 h. Trypomastig-
otes did not survive to H2O2 concentrations higher than 50 lM,
whilst, epimastigotes can bear concentrations in the order of
200 lM H2O2 (Peloso et al., 2011). Consequently, H2O2 concentra-
tions lower than 50 lM were used in the experiments described
below.
TcCPx expression in trypomastigotes submitted to an H2O2
challenge (denominated here as intracellular, Fig. 1A) and in the
supernatant of the incubation medium (Fig. 1C) was performed.
In Fig. 1E, a graphical analysis of the results is shown. TcCPx levels
in cells exposed to 10 lM H2O2 had a slight but signiﬁcant increase
compared to the control (5.4%), followed by a steep reduction in
TcCPx levels (61.7%) at 30 lM H2O2 (Fig. 1E, white bars). At
40 lM, TcCPx expression was equivalent to 30 lM-treated cells,
but at 50 lM, there was an increase (13.2%) compared to 40 lM-
treated cells (Fig. 1E, white bars). Regarding the trypomastigote
proteins released into the incubation medium under H2O2-treat-
ment, decreased TcCPx expression at 10 lM was observed, fol-
lowed by an increase in expression that directly correlated until
an H2O2 concentration of 50 lM, when a 20% decrease compared
to the levels observed in the 40 lM H2O2-treated cells was de-
tected (Fig. 1E, black bars).
Regarding TcMPx expression (Fig. 2), an increase of 52.8% was
observed with 10 lM H2O2 treatment compared to the control,
with a gradual decrease in its expression with increasing H2O2-
concentrations. Interestingly, no TcMPx could be detected in the
supernatant of the H2O2 incubation medium.
In order to conﬁrm that the release of TcCPx under H2O2 treat-
ment was not a consequence of parasite lysis and also that cell
integrity was not altered upon this treatment, the microscopy of
the cells was carried out. In Fig. 3(A–F) it is shown that under
our experimental conditions, the cell morphology did not change
under the H2O2 treatment.
Additionally, TcMPx and TcCPx expression in the epimastigotes
and trypomastigotes forms was evaluated. In Fig. 4 it is shown that
the trypomastigotes have higher levels of both enzymes (25.3% and
111.5% for TcMPx and TcCPx, respectively) compared to the non-
infective form.4. Discussion
T. cruzi resistance to oxidative stress is associated with its rep-
ertoire of antioxidant enzymes. Before their differentiation into the
metacyclic form, the epimastigotes are exposed to an oxidative
environment due to the presence of heme in the vector’s intestinal
tract (Paes et al., 2011). This compound, besides acting as a prolif-
eration factor, at high levels, has an important cytotoxic action
through ROS generation (Afonso et al., 1996; Kumar and Bandyo-
padhyay, 2005; Paes et al., 2011) that can occur during the degra-
dation of hemoglobin, which leads to the release of large amounts
of heme (Paes et al., 2011). Additionally, the trypomastigotes have
to tolerate high levels of ROS and RNS produced by macrophages
(Kierszenbaum et al., 1974), rendering the T. cruzi’s antioxidant de-
fense system essential for the parasite’s survival.
The differential pattern of protein expression in T. cruzi is
noticeable during the metacyclogenesis process, although some
proteins do not change in the different forms of the parasite. Paba
et al. (Paba et al., 2004) showed through proteomic analysis that
the majority of the proteins have the same level of expression in
the three forms of the parasite, suggesting that the features of each
T. cruzi stage is the result of the differential expression of a reduced
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Fig. 1. TcCPx expression analysis in tissue-cultured trypomastigotes and in the supernatant of the H2O2-incubated medium. Trypomastigotes (5  107 cells/mL) were
incubated in the presence of 0–50 lM H2O2 at 37 C for 2 h. T. cruzi lysates and the supernatant lyophilization were prepared as described. (A) Western blotting (a-TcCPx) of
parasite lysates (intracellular); (B) Western blotting (a-TcGAPDH) for (A). Lanes 1: 0 lM (control), 2: 10 lM, 3: 20 lM, 4: 30 lM, 5: 40 lM, 6: 50 lM H2O2. (C) Western
blotting analysis (a-TcCPx) of the supernatant of the incubation medium. (D) Coomassie Blue staining of supernatant proteins loaded. (E) The percentage of the band
intensities of (A) or (C) were normalized to their respective bands in lane 1, which were set to 100%. The best representative of two independent experiments is shown.
Statistical analysis: t test, p > 0.05 for the indicated groups.
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Fig. 2. Western blotting analysis of TcMPx expression in tissue-cultured trypomastigotes. Trypomastigotes (5  107 cells/mL) were incubated in the presence of 0–50 lM
H2O2 at 37 C for 2 h. T. cruzi lysates were prepared as described. (A) Western blotting (a-TcMPx) of parasite lysates; Lanes 1: 0 lM (control), 2: 10 lM, 3: 20 lM, 4: 30 lM, 5:
40 lM, 6: 50 lM H2O2. (B) Western blotting analysis of a-TcGAPDH for (A). (C) The percentage of the band intensity for (A) was normalized to the band in lane 1, which was
set to 100%. The best representative of two independent experiments is shown. Statistical analysis: t test, p < 0.05.
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differential expression of 60 proteins between the amastigote and
promastigote forms was observed (El Fakhry et al., 2002). Addition-
ally, Díaz et al. identiﬁed similarities among the proteins of T. cruzi
present in the three forms; however a higher differential expression
of the proteins involved in the antioxidant defense was observed
(Díaz et al., 2011). Although, trypanosomatids are devoid of catalase
or selenium glutathione peroxidase, the presence of a series of
pathways centered in trypanothione (Krauth-Siegel and Comini,
2008) allows the parasite to some extent to tolerate the oxidative
stresses coming from exogenous or even endogenous sources.
Among these proteins, as part of the antioxidant defense system,
TcCPx and TcMPx have been the subject of many studies due to
their role in infectivity (Piacenza et al., 2008), despite having no
effect on the invasion process (Piñeyro et al., 2008).In relation to the levels of TcCPx released into the supernatant
after H2O2-treatment, a concomitant increase in its expression
was observed with the increase in the H2O2 concentration used,
whereas a decrease in intracellular TcCPx expression was observed.
Importantly, TcCPx expression did not increase in relation to the
levels observed under no treatment, except for 10 lM H2O2. How-
ever, it was demonstrated that with the epimastigote form, the
treatment with different concentrations of H2O2 led to an increase
in TcCPx expression levels suggesting that this enzyme protects the
parasite against the ﬂuctuating levels of ROS generated during
physiological processes (Finzi et al., 2004). Regarding TcMPx
expression proﬁle in tissue culture-derived trypomastigotes sub-
mitted to H2O2 treatment it was different from the one observed
for TcCPx because a signiﬁcant increase followed by a decrease in
its expression was detected. Most importantly, no TcMPx could
Fig. 3. Morphological analysis of tissue-culture derived trypomastigotes treated with H2O2. Trypomastigotes (5  107 cells/mL) were incubated in the presence of 0–50 lM
H2O2 at 37 C for 2 h. After this period the cells were prepared as described. (A1 and A2): control (0 lM), (B1 and B2): 10 lM, (C1 and C2): 20 lM, (D1 and D2): 30 lM, (E1 and
E2): 40 lM and (F1 and F2): 50 lM.
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Fig. 4. Epimastigotes have lower expression levels of TcCPx and TcMPx compared to tissue-culture derived trypomastigotes. T. cruzi lysates from epimastigotes and
trypomastigotes subjected to no treatment were prepared as described. (A) Western blotting (a-TcMPx); (B) Western blotting (a-TcCPx); (C) Loading control with
a-TcGAPDH; Lanes 1: epimastigote, 2: trypomastigote. (D) The percentages of the band intensities of (A) or (B) were normalized to their respective bands in lane 1, which
were set to 100%. The best representative of two independent experiments is shown. Statistical analysis: t test, p < 0.05.
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noteworthy to highlight that these peroxiredoxins respond differ-
ently to H2O2, a signaling molecule (Rhee et al., 2005), since
10 lM H2O2 led to a marked increase in TcMPx, but a slight
increase in intracellular TcCPx levels. In this sense, it can be sug-
gested that lower levels of H2O2 (around 10 lM) would signal to
an increase in the levels of both peroxiredoxins, but TcMPx is
increased in higher levels than TcCPx possibly to protect mitochon-
drial integrity, since this parasite has just one mitochondrion per
cell. However, the exact mechanism by which each peroxiredoxin
respond to H2O2 remains to be elucidated.
In addition, bioinformatic analyses of the TcCPx and TcMPx se-
quences did not predict any signal peptide for secretion (TargetP
1.1 server); however, TcCPx was detected in the incubation
medium.In eukaryotic cells, proteins can be secreted by the classical or
unconventional pathway. The former involves the recognition of
a signal sequence in proteins to be exported, while the latter does
not require the presence of these signal peptides in the protein
(Nickel, 2005, 2010; Nickel and Rabouille, 2009). In trypanosomat-
ids, the unconvencional sequence pathway appears to be relevant
for the parasite-host interplay. For example, membrane vesicles
shed by T. cruzi were described some years ago (Gonçalves et al.,
1991) and afterwards related to the parasite infectivity (Trocoli
Torrecilhas et al., 2009). In addition, the majority of the secreted
proteins from Leishmania donovani lacks the classical peptide sig-
nals (Silverman et al., 2008). Furthermore, the proteomic charac-
terization of released/secreted proteins from Leishmania
braziliensis showed that only 5% of the identiﬁed proteins have a
classical secretion sequence and 57% were released following
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reported for Trypanosoma brucei, where a signiﬁcant proportion of
the proteins in the secretome lack a transit peptide and are most
likely not secreted through the classical sorting pathway (Geiger
et al., 2010). Interestingly, comparing the actively secreted proteins
and the functional categories, a close relationship between the
secretomes of Trypanosoma and Leishmania was demonstrated
(Geiger et al., 2010).
Regarding the function of the secreted proteins, in Leishmania,
some of them are involved in proteolytic and antioxidant activities,
which could contribute to the parasite’s intracellular survival and/
or pathogenesis (Silverman et al., 2008). Supporting our results, in
L. braziliensis promastigotes, one of the proteins secreted was iden-
tiﬁed as a tryparedoxin peroxidase (Cuervo et al., 2009). In addi-
tion, in L. donovani proteins with antioxidant activities such as
superoxide dismutase, trypanothione reductase and a putative glu-
tathione peroxidase-like protein were also secreted (Silverman
et al., 2008).
The presence of the peroxiredoxin in the extracellular medium
could help the parasite to counteract the ROS and RNS produced by
the host avoiding in this way that a higher concentration of these
molecules reaches it. In addition, it was postulated that tumor-
secreted peroxiredoxins could modulate the surrounding immune
microenvironment to one that is beneﬁcial for the proliferation and
migration of tumor cells (Robinson et al., 2010). If this is also true
for a parasite’s peroxiredoxin, it remains to be determinated.
In relation to the TcCPx and TcMPx expression levels in tissue
culture-derived trypomastigotes and epimastigotes, it is clear that
the former and also the metacyclic forms (Piacenza et al., 2009b)
have higher ones. Additionally, bloodstream trypomastigotes
(C3C clone) were more resistant to H2O2-treatment compared to
epimastigotes (Tanaka et al., 1983), suggesting that in these cells
the levels of peroxiredoxins must also be higher compared to the
non-infective forms. In contrast with our results, Piñeyro et al.
(Piñeyro et al., 2008) reported for T. cruzi, Dm28c strain, that TcCPx
and TcMPx levels were similar in all stages of the parasite. The high
degree of both structural and functional heterogeneity among the
T. cruzi strains (Brisse et al., 1998; Dvorak et al., 1988) that could
modulate their pathogenicity, survival and adaptability (Brisse
et al., 1998; Engel et al., 1990) may explain the contradictory
results.
In summary, our results show that upon incubation with H2O2,
TcCPx is released into the incubation medium with a concomitant
decrease in its intracellular concentration. In contrast, TcMPx had
increased expression when the cells were treated with H2O2 in
the range of 10–30 lM, but it was not released into the incubation
medium. These results suggest that cytosolic and mitochondrial
peroxiredoxins in tissue culture-derived trypomastigotes have a
different pattern of expression upon H2O2-induced oxidative
stress, raising new questions regarding the distinct roles played
by these proteins in protecting the parasite against this stress.
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